Back to Journals » Vascular Health and Risk Management » Volume 8

Lower extremity venous thrombosis in patients younger than 50 years of age

Authors Kreidy R, Salameh P, Waked M

Received 24 December 2011

Accepted for publication 16 January 2012

Published 13 March 2012 Volume 2012:8 Pages 161—167

DOI https://doi.org/10.2147/VHRM.S29457

Review by Single-blind

Peer reviewer comments 2

Raghid Kreidy1, Pascale Salameh2, Mirna Waked3

1Department of Vascular Surgery, Saint George Hospital, University Medical Center, University of Balamand, 2Laboratory of Clinical and Epidemiological Research, Faculty of Pharmacy, Lebanese University, 3Department of Pulmonary Medicine, Saint George Hospital, University Medical Center, University of Balamand, Beirut, Lebanon

Aim: Lower extremity deep venous thrombosis in the young adult is uncommon and has not been well studied in the literature. The aim of this study is to define risk factors for deep venous thrombosis among patients younger than 50 years of age, to compare them with a control group, and to suggest recommendations for the management and treatment of venous thrombosis in this particular group of patients.
Methods: From January 2003 to January 2011, 66 consecutive Lebanese patients (29 males and 37 females) younger than 50 years, diagnosed in an academic tertiary-care center with lower extremity deep venous thrombosis by color flow duplex scan, were retrospectively reviewed. Their age varied between 21 and 50 years (mean 38.7 years). The control group included 217 patients (86 males and 131 females) older than 50 years (range: 50–96 years; mean 72.9 years).
Results: The most commonly reported risk factors in the younger age group were inherited thrombophilia (46.9% compared with 13.8% in the control group; P < 0.001), pregnancy (18.2% compared with 0.5%; P < 0.001), treatment with estrogen drugs (13.6% compared with 2.3%; P = 0.001), and family history of venous thromboembolism (9.1% compared with 3.8%; P = 0.084).
Conclusion: Inherited thrombophilia is the most commonly observed risk factor among patients younger than 50 years, with a prevalence of three times more than the control group. Young adults should be screened for thrombophilia even in the presence of transient acquired risk factors. Pregnancy and treatment with estrogen drugs essentially when associated with inherited thrombophilia represent a frequent cause of venous thrombosis among young female patients. Inferior vena cava abnormalities should be excluded in young patients with spontaneous proximal venous thrombosis especially when recurrent venous thrombosis or resistance to anticoagulation are observed.

Keywords: venous thrombosis, lower extremities, young patient, risk factors, genetics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Readers of this article also read:

Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition

Zaccaria A, Roux-Dalvai F, Bouamrani A, Mombrun A, Mossuz P, Monsarrat B, Berger F

International Journal of Nanomedicine 2015, 10:1869-1883

Published Date: 9 March 2015

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR

Vascular Health and Risk Management 2014, 10:237-246

Published Date: 25 April 2014

The "Pulse Time Index of Norm" highly correlates with the left ventricular mass index in patients with arterial hypertension

Posokhov IN, Kulikova NN, Starchenkova IV, Grigoricheva EA, Evdokimov VV, Orlov AV, Rogoza AN

Vascular Health and Risk Management 2014, 10:139-144

Published Date: 19 March 2014

The potential benefit of stem cell therapy after stroke: an update

Banerjee S, Williamson DA, Habib N, Chataway J

Vascular Health and Risk Management 2012, 8:569-580

Published Date: 10 October 2012

The role of inflammation in diabetic cardiomyopathy

Nunes S, Soares E, Pereira FC, Reis F

International Journal of Interferon, Cytokine and Mediator Research 2012, 4:59-73

Published Date: 24 July 2012

Corrigendum

De Caterina AR, Harper AR, Cuculi F

Vascular Health and Risk Management 2012, 8:443-445

Published Date: 19 July 2012

Lift the quilt in case of atrial fibrillation and disc prolapse

Bastovansky A, Ziegler K, Stöllberger C, Finsterer J

Vascular Health and Risk Management 2012, 8:389-392

Published Date: 22 June 2012

Surgery in current therapy for infective endocarditis

Head SJ, Mokhles MM, Osnabrugge RLJ, Bogers AJJC, Kappetein AP

Vascular Health and Risk Management 2011, 7:255-263

Published Date: 19 April 2011